Use our immune-oncology IVD solutions IMMUNOSCORE® in Localized Colon Cancer and IMMUNOSCORE® IC in Non-Small Cell Lung Cancer to improve patient care management with immune contexture information.
Immunoscore® is an in vitro diagnostic test predicting the risk of relapse in early stage colon cancer patients, by measuring the host immune response at the tumor site. This test can be ordered by oncologists for their patients for a better disease management.
Immunoscore ® IC is an assay for the detection of PD-L1 protein and the concomitant detection of CD8 + cells in Non-Small Cell Lung cancer (NSCLC) tissue.